NO864993D0 - 2-((3,5-dihalo-4-aminobenzyl))imidazoliner. - Google Patents

2-((3,5-dihalo-4-aminobenzyl))imidazoliner.

Info

Publication number
NO864993D0
NO864993D0 NO864993A NO864993A NO864993D0 NO 864993 D0 NO864993 D0 NO 864993D0 NO 864993 A NO864993 A NO 864993A NO 864993 A NO864993 A NO 864993A NO 864993 D0 NO864993 D0 NO 864993D0
Authority
NO
Norway
Prior art keywords
aminobenzyl
dihalo
imidazoline
Prior art date
Application number
NO864993A
Other languages
English (en)
Other versions
NO864993L (no
Inventor
Martin Winn
John Francis Debernardis
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO864993D0 publication Critical patent/NO864993D0/no
Publication of NO864993L publication Critical patent/NO864993L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicinal Preparation (AREA)
NO864993A 1985-12-11 1986-12-10 2-((3,5-dihalo-4-aminobenzyl))imidazoliner. NO864993L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/807,921 US4665095A (en) 1985-12-11 1985-12-11 Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion

Publications (2)

Publication Number Publication Date
NO864993D0 true NO864993D0 (no) 1986-12-10
NO864993L NO864993L (no) 1987-06-12

Family

ID=25197433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864993A NO864993L (no) 1985-12-11 1986-12-10 2-((3,5-dihalo-4-aminobenzyl))imidazoliner.

Country Status (9)

Country Link
US (1) US4665095A (no)
EP (1) EP0230532B1 (no)
JP (1) JPH07116038B2 (no)
AU (1) AU591740B2 (no)
CA (1) CA1282334C (no)
DE (1) DE3674569D1 (no)
FI (1) FI865025A (no)
NO (1) NO864993L (no)
NZ (1) NZ218334A (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
JP4096363B2 (ja) * 1997-03-14 2008-06-04 日本新薬株式会社 鼻又は眼の充血治療剤
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
CA2327543A1 (en) * 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes
AU2007209381A1 (en) * 2006-01-27 2007-08-02 F. Hoffmann-La Roche Ag Use of substituted 2-imidazole of imidazoline derivatives
ATE546437T1 (de) * 2006-10-19 2012-03-15 Hoffmann La Roche Aminomethyl-4-imidazole
CA2665255A1 (en) * 2006-10-19 2008-04-24 F. Hoffmann-La Roche Ag Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
CA2668454A1 (en) * 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles
KR101134226B1 (ko) * 2006-11-16 2012-04-10 에프. 호프만-라 로슈 아게 치환된 4-이미다졸
KR101189348B1 (ko) * 2006-12-13 2012-10-09 에프. 호프만-라 로슈 아게 미량 아민 결합 수용체(ｔａａｒ)에 대한 리간드로서의 신규한 2-이미다졸
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
ES2510546T3 (es) 2007-02-02 2014-10-21 F. Hoffmann-La Roche Ag Nuevas 2-aminooxazolinas como ligandos TAAR1 para trastornos del SNC
KR101335845B1 (ko) * 2007-02-15 2013-12-02 에프. 호프만-라 로슈 아게 Ｔａａｒ1 리간드로서의 2-아미노옥사졸린
JP2010531837A (ja) 2007-07-02 2010-09-30 エフ．ホフマン−ラ ロシュ アーゲー 微量アミン関連レセプター（ｔａａｒ）に対して良好な親和性を有する２−イミダゾリン
EP2173719A1 (en) * 2007-07-03 2010-04-14 F. Hoffmann-Roche AG 4-imidazolines and their use as antidepressants
JP2010534701A (ja) * 2007-07-27 2010-11-11 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒリガンドとしての２−アゼチジンメタンアミン及び２−ピロリジンメタンアミン
WO2009016088A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of cns disorders
BRPI0814758A2 (pt) * 2007-08-03 2015-03-03 Hoffmann La Roche Piridinacarboxamida e derivados de benzamida como ligantes taar1
JP5546455B2 (ja) * 2007-10-02 2014-07-09 リグスホスピタル 交感神経系α‐および／またはβ‐アドレナリン受容体に対してアゴニスト作用を有する交感神経作動薬の血餅強度改善に関連した全身的止血促進効果
RU2513086C2 (ru) * 2008-07-24 2014-04-20 Ф.Хоффманн-Ля Рош Аг Производные 4,5-дигидро-оксазол-2-ила
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
AU2017234042B2 (en) 2016-03-17 2020-11-19 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of TAAR
EP3634528B1 (en) 2017-06-07 2023-06-07 Shifamed Holdings, LLC Intravascular fluid movement devices, systems, and methods of use
JP7319266B2 (ja) 2017-11-13 2023-08-01 シファメド・ホールディングス・エルエルシー 血管内流体移動デバイス、システム、および使用方法
CN117959583A (zh) 2018-02-01 2024-05-03 施菲姆德控股有限责任公司 血管内血泵以及使用和制造方法
JP2022540616A (ja) 2019-07-12 2022-09-16 シファメド・ホールディングス・エルエルシー 血管内血液ポンプならびに製造および使用の方法
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868802A (en) * 1959-01-13 Nxchj
US2731471A (en) * 1956-01-17 Nxg hi
DE1617618B2 (de) * 1966-06-18 1976-05-20 Merck Patent Gmbh, 6100 Darmstadt Schleimhautabschwellende mittel zur lokalen applikation
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
US3660423A (en) * 1970-02-13 1972-05-02 Dow Chemical Co 2-(substituted benzyl)methyl-2-imidazolines
US3922282A (en) * 1975-01-17 1975-11-25 American Home Prod 2-Aryl-2-imidazoline-1-propionic acids and their esters
AU1623483A (en) * 1978-02-01 1983-10-13 Wellcome Foundation Limited, The Formulations of imidazole derivatives
US4506074A (en) * 1982-11-08 1985-03-19 Merck & Co., Inc. 2-[2-Pyridinyloxy(thio or amino)methyl]-1H-imidazoles and derivatives
US4461914A (en) * 1983-02-01 1984-07-24 American Cyanamid Company Method for the preparation of 1-(4'-amino-3',5'-dichlorophenyl)-2-alkyl(or dialkyl)aminoethanols
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique

Also Published As

Publication number Publication date
EP0230532B1 (en) 1990-09-26
NZ218334A (en) 1989-03-29
AU6631986A (en) 1987-06-18
US4665095A (en) 1987-05-12
JPH07116038B2 (ja) 1995-12-13
CA1282334C (en) 1991-04-02
DE3674569D1 (de) 1990-10-31
FI865025A (fi) 1987-06-12
JPS62145067A (ja) 1987-06-29
NO864993L (no) 1987-06-12
AU591740B2 (en) 1989-12-14
FI865025A0 (fi) 1986-12-10
EP0230532A1 (en) 1987-08-05

Similar Documents

Publication Publication Date Title
NO864993D0 (no) 2-((3,5-dihalo-4-aminobenzyl))imidazoliner.
DE3577547D1 (de) 2-(2'-nitrobenzoyl)-1,3-cyclohexandionen.
FI861210A0 (fi) N,n'-dialkylguanidinodipeptider.
FI853193A0 (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
ATE38827T1 (de) Bestimmte 2-(2'-alkylbenzoyl)-1,3cyclohexandione.
DE3669876D1 (de) 3,4-dihydrobenzopyranderivate.
DE3775802D1 (de) 2-(4'-alkoxyphenyl)-5-alkylpyridine.
MX21592A (es) 1,3-oxazolidin-2-ona.
NL971040I2 (nl) 1-Dimethylcarbamoyl-3-gesubstitueerde-5-gesubstitueerde-1H-1,2,4-triazolen.
ATE45741T1 (de) 1-oxa-3-oxo-4,8-diaza-spiro-(4,5>decanverbindungen.
IT8521944A0 (it) 1,4-diidropiridine-2-sostituite.
DE3674054D1 (de) 1,3-disubstituierte imidazoliumsalze.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI863300A0 (fi) 7-oxo-4-tia-1-azabicyclo/3,2,0/ hept-2-enderivat.
FI861950A0 (fi) 1,3-dioxan-etrar.
ATE74912T1 (de) 2,2'-bi-1h-imidazole.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI865158A0 (fi) 1-h-pyrido/3,2//1,4/-tiaziner.
IT8620495A0 (it) 2,4-dicloro-5-nitro-tiazolo.
DE3674284D1 (de) Kationische 1,2,3-thiadiazolazoverbindungen.
DE3678154D1 (de) 2-(arylbenzothiazin)-derivate.
ATE61586T1 (de) 2-(arylbenzothiazin)-derivate.
ATE45349T1 (de) Substituierte 2,3,4,9-tetrahydro-1h-carbazol-1essigs|urederivate.
NO892008L (no) Substituert 1,2,4-oksadiazol.